| Shelby Schumer, MOT | |
|
1719 Clawson St, Alton, IL 62002-4702 | |
| (217) 409-6405 | |
| Not Available |
| Full Name | Shelby Schumer |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1719 Clawson St, Alton, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649904921 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | Schwegel Physical Therapy Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1629390869 PECOS PAC ID: 0941334213 Enrollment ID: O20100823000615 |
News Archive
New guidance has been released today by the National Institute for Health and Care Excellence (NICE) recommending Olympus Medical's transurethral resection in saline (TURis) system for use in surgery to reduce the size of enlarged prostate glands in men. NICE published the guidance in light of the potential it offers NHS hospitals to realise substantial cost savings of £285-£375 per patient whilst also improving patient outcomes.
Centene Corporation announced today that Managed Health Services (MHS), its Indiana subsidiary, won the 2011 National Environmental Leadership Award (Health Plan Division) in Asthma Management from the EPA (Environmental Protection Agency).
A team of Italian scientists reported this week that blocking the interaction between urokinase receptor (uPAR) and formyl peptide receptor type 1 (FPR1) suppresses the ability of melanoma cells to migrate, invade through an extracellular matrix, and to burrow through a layer of endothelial cells.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.
Researchers from the David Geffen School of Medicine at UCLA found that cardiovascular disease patients who have high muscle mass and low fat mass have a lower mortality risk than those with other body compositions. The findings also suggest that regardless of a person's level of fat mass, a higher level of muscle mass helps reduce the risk of death.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shelby Schumer, MOT 1719 Clawson St, Alton, IL 62002-4702 Ph: (217) 409-6405 | Shelby Schumer, MOT 1719 Clawson St, Alton, IL 62002-4702 Ph: (217) 409-6405 |
News Archive
New guidance has been released today by the National Institute for Health and Care Excellence (NICE) recommending Olympus Medical's transurethral resection in saline (TURis) system for use in surgery to reduce the size of enlarged prostate glands in men. NICE published the guidance in light of the potential it offers NHS hospitals to realise substantial cost savings of £285-£375 per patient whilst also improving patient outcomes.
Centene Corporation announced today that Managed Health Services (MHS), its Indiana subsidiary, won the 2011 National Environmental Leadership Award (Health Plan Division) in Asthma Management from the EPA (Environmental Protection Agency).
A team of Italian scientists reported this week that blocking the interaction between urokinase receptor (uPAR) and formyl peptide receptor type 1 (FPR1) suppresses the ability of melanoma cells to migrate, invade through an extracellular matrix, and to burrow through a layer of endothelial cells.
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.
Researchers from the David Geffen School of Medicine at UCLA found that cardiovascular disease patients who have high muscle mass and low fat mass have a lower mortality risk than those with other body compositions. The findings also suggest that regardless of a person's level of fat mass, a higher level of muscle mass helps reduce the risk of death.
› Verified 3 days ago
Robin Ileana Foster, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Glenhaven Dr, Alton, IL 62002 Phone: 618-462-1500 | |
Meagan Kallal, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Saint Anthonys Way, Alton, IL 62002 Phone: 618-463-5171 | |
Carol Grapperhaus, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3550 College Ave, Suite A, Alton, IL 62002 Phone: 618-465-6566 Fax: 618-465-6573 | |
Mrs. Margaret Miller Brorby, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7429 | |
Mrs. Carol L Babcock, OTR-L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 915 E 5th St, Alton, IL 62002 Phone: 618-377-2449 | |
Amy Renee Niewald, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7429 | |
Mrs. Emily E Gehrke, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7429 Fax: 618-463-7808 |